BCL2L13 anticorps (AA 224-459)
Aperçu rapide pour BCL2L13 anticorps (AA 224-459) (ABIN187489)
Antigène
Voir toutes BCL2L13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 224-459
-
Specificité
- Recognizes the C-terminus of human Bcl-rambo (aa 224-459). Detects endogenous proteins by ICC, IP and WB. Species Reactivity: Human. Other species not tested.
-
Pureté
- > 95 % by SDS-PAGE analysis.
-
Immunogène
- Recombinant human Bcl-rambo fused at the N-terminus to a tag.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Western blot: Use at a 1:1,000 dilution. Immunoprecipitation: Use at a 1:100 dilution. Immunocytochemistry: Use at a 1:300 dilution. The optimal dilution for a specific application should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 100 µL of antibody purified from concentrated hybridoma tissue culture supernatant. Antibody is at 1 mg/mL in PBS with 0.02% sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
-
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
-
Autre désignation
- Bcl-2-like 13
-
Pathways
- Positive Regulation of Endopeptidase Activity
Antigène
-